{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,226.15",
    "chg": 51.05,
    "chgp": "4.34%",
    "dir": 1,
    "prev_price": "1,175.10",
    "mcapval": "71,214.99 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE406A01037",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "30.96 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "164981",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Aurobindo Pharma Ltd",
      "datetime": "01-Feb-2026",
      "details": "The Exchange has sought clarification from Aurobindo Pharma Ltd on February 01 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Significant Volume Movement In CompanyS Shares",
      "datetime": "31-Jan-2026",
      "details": "Submission of clarification on significant volume movement in Companys shares sought vide letter No.NSE/CM/Surveilance/16398 dated January 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Date",
      "datetime": "30-Jan-2026",
      "details": "Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve This is to inform that a Meeting of the Board of Directors of the Company will be held on Monday February 9 2026 to consider and approve inter alia the Standalone & Consolidated Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News